Work

Author response: DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers

Year: 2024

Type: peer-review

Source: eLife

DOI: 10.7554/elife.89017.2.sa3

Authors: Jose Mario Bello Pineda, Robert K. Bradley

Institution: Fred Hutch Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,500

OpenAlex ID: W4394678815

Cites:

Cited by:

Related to: 10